Trial Profile
A Double-blind, Placebo-controlled Pilot Trial to Investigate the Administration of Von Willebrand Factor Concentrate (Willfact, LFB France) in Adult Patients During Extracorporeal Membrane Oxygenation
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2022
Price :
$35
*
At a glance
- Drugs Von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- 26 Nov 2021 Status changed from active, no longer recruiting to discontinued.
- 11 Mar 2020 Status changed from recruiting to active, no longer recruiting.
- 07 Nov 2017 New trial record